GA NCORP

Doctors

Asad Bashey MD, PhD

Blood and Marrow Transplant Program at Northside Hospital Cancer Institute
www.bmtga.com

Education & Training

Specialty and Certification

Medical Oncology / Board Certified

Clinical Trial Cancer Types

Hematologic Malignancies, Lymphoma, Multiple Myeloma, Multiple Primaries, Non-Hodgkin Lymphoma

Affliations


Northside Hospital Cancer Center
Blood and Marrow Transplant Program at Northside Hospital


Active Clinical Trial Sites


Northside Hospital Cancer Institute

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355 (p)
www.northside.com

driving directions

Clinical Trials

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
Cancer Type: Hematologic Malignancies

A Phase 1, Multicenter, Open-Label Study of JCAR017, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, for Relapsed and Refractory (R / R) B-cell Non-Hodgkin Lymphoma (NHL)
Cancer Type: Lymphoma

A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Triplet Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)
Cancer Type: Lymphoma

A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Triplet Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)
Cancer Type: Multiple Myeloma

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Cancer Type: Multiple Primaries

A Randomized Double-blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Cancer Type: Non-Hodgkin Lymphoma

A Phase 1, Multicenter, Open-Label Study of JCAR017, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, for Relapsed and Refractory (R / R) B-cell Non-Hodgkin Lymphoma (NHL)
Cancer Type: Non-Hodgkin Lymphoma
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org